BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antimicrobial activities of novel 1,2,4-triazolo [3,4-a] phthalazine derivatives. 2014

Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, KeXue DaDao, Zhengzhou 450001, China.

A series of novel 1,2,4-triazolo [3,4-a] phthalazine derivatives were synthesized in five steps from a common precursor, phthalic anhydride. Most of synthesized phthalazine derivatives showed inhibitory activity against Staphylococcus aureus. One of phthalazine derivatives 5l showed inhibitory activity against all tested bacterial and fungal strains.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010793 Phthalazines Bicyclic heterocyclic compounds containing a BENZENE ring fused to PYRIDAZINE.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
3-Methyl-1,2,4-triazolo[3,4-a]phthalazine monohydrate.
October 2009, Acta crystallographica. Section E, Structure reports online,
Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
Synthesis and positive inotropic evaluation of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted piperazine moieties.
April 2014, Bioorganic & medicinal chemistry letters,
Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
Synthesis and anticonvulsant activity evaluation of 6-substituted-[1,2,4]triazolo[3,4-a](tetrazolo[5,1-a])phthalazine derivatives.
August 2013, Journal of enzyme inhibition and medicinal chemistry,
Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
Synthesis and anti-inflammatory activity evaluation of some novel 6-alkoxy(phenoxy)-[1,2,4]triazolo[3,4-a]phthalazine-3-amine derivatives.
November 2010, European journal of medicinal chemistry,
Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
Synthesis and anti-inflammatory activity evaluation of a novel series of 6-phenoxy-[1,2,4]triazolo[3,4-a]phthalazine-3-carboxamide derivatives.
March 2016, Bioorganic & medicinal chemistry letters,
Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
Synthesis and antimicrobial activities of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines carrying thioalkyl and sulphonyl phenoxy moieties.
April 2007, European journal of medicinal chemistry,
Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
Synthesis and antimicrobial activity of some novel fused heterocyclic 1,2,4-triazolo [3,4-b][1,3,4] thiadiazine derivatives.
April 2014, Journal of advanced pharmaceutical technology & research,
Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
Synthesis and antimicrobial testing of 4H-1,2,4-triazole, 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazine derivatives of 1H-benzimidazole.
November 1997, Die Pharmazie,
Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
Synthesis and biological evaluation of [1,2,4]triazolo[3,4-a]phthalazine and tetrazolo[5,1-a]phthalazine derivatives bearing substituted benzylpiperazine moieties as positive inotropic agents.
May 2013, Chemical biology & drug design,
Qiu-Rong Zhang, and Deng-Qi Xue, and Peng He, and Kun-Peng Shao, and Peng-Ju Chen, and Yi-Fei Gu, and Jing-Li Ren, and Li-Hong Shan, and Hong-Min Liu
Synthesis, antimicrobial and anti-inflammatory activities of some 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines bearing trichlorophenyl moiety.
April 2008, European journal of medicinal chemistry,
Copied contents to your clipboard!